
LINK . SPRINGER . COM {
}
Title:
Targeting tumor vasculature with novel Listeria-based vaccines directed against CD105 | Cancer Immunology, Immunotherapy
Description:
The FDA approval of bevacizumab (Avastin®, Genentech/Roche), a monoclonal antibody raised against human VEGF-A, as second-line therapy for colon and lung carcinoma validated the approach of targeting human tumors with angiogenesis inhibitors. While the VEGF/VEGFR pathway is a viable target for anti-angiogenesis tumor therapy, additional targets involved in tumor neovascularization have been identified. One promising target present specifically on tumor vasculature is endoglin (CD105), a member of the TGF-β receptor complex expressed on vascular endothelium and believed to play a role in angiogenesis. Monoclonal antibody therapy and preventive vaccination against CD105 has met with some success in controlling tumor growth. This report describes the in vivo proof-of-concept studies for two novel therapeutic vaccines, Lm-LLO-CD105A and Lm-LLO-CD105B, directed against CD105 as a strategy to target neovascularization of established tumors. Listeria-based vaccines directed against CD105 lead to therapeutic responses against primary and metastatic tumors in the 4T1-Luc and NT-2 mouse models of breast cancer. In a mouse model for autochthonous Her-2/neu-driven breast cancer, Lm-LLO-CD105A vaccination prevented tumor incidence in 20% of mice by week 58 after birth while all control mice developed tumors by week 40. In comparison with previous Listeria-based vaccines targeting tumor vasculature, Lm-LLO-CD105A and Lm-LLO-CD105B demonstrated equivalent or superior efficacy against two transplantable mouse models of breast cancer. Support is provided for epitope spreading to endogenous tumor antigens and reduction in tumor vascularity after vaccination with Listeria-based CD105 vaccines. Reported here, these CD105 therapeutic vaccines are highly effective in stimulating anti-angiogenesis and anti-tumor immune responses leading to therapeutic efficacy against primary and metastatic breast cancer.
Website Age:
28 years and 1 months (reg. 1997-05-29).
Matching Content Categories {📚}
- Health & Fitness
- Education
- Science
Content Management System {📝}
What CMS is link.springer.com built with?
Custom-built
No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.
Traffic Estimate {📈}
What is the average monthly size of link.springer.com audience?
🌠 Phenomenal Traffic: 5M - 10M visitors per month
Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.
check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush
How Does Link.springer.com Make Money? {💸}
We don’t know how the website earns money.
Some websites aren't about earning revenue; they're built to connect communities or raise awareness. There are numerous motivations behind creating websites. This might be one of them. Link.springer.com has a revenue plan, but it's either invisible or we haven't found it.
Keywords {🔍}
scholar, google, cancer, pubmed, cas, article, tumor, breast, endoglin, angiogenesis, vaccines, mice, tumors, paterson, res, targeting, vasculature, listeriabased, vascular, growth, mouse, vaccine, cells, human, cell, pan, metastatic, immunol, biol, therapy, target, role, therapeutic, model, endothelial, listeria, bernabeu, solid, mammary, transgenic, privacy, cookies, content, immunotherapy, tsai, seavey, monoclonal, receptor, responses, access,
Topics {✒️}
lm-llo-cd105b demonstrated equivalent anti-endoglin monoclonal antibodies listeria monocytogenes-based vaccines dose-dense doxorubicin/cyclophosphamide chemotherapy tgf-beta-receptor complex month download article/chapter lm-llo-cd105a-vaccinated mice matthew seavey & yvonne paterson listeria-based vaccines directed listeria-based cd105 vaccines tgf-beta superfamily coreceptors anti-angiogenesis tumor therapy stimulate ifn-γ secretion antiangiogenic chimeric anti-endoglin hiv gag-specific cd8 + vascular-specific tgfbeta coreceptor ifn-γ-producing splenocytes algire gh murine s-endoglin isoform cancer immunotherapy targeting listeria-based vaccine listeria-based vaccines myeloid-derived suppressor cells 2/neu-driven breast cancer article cancer immunology stimulating anti-angiogenesis ifn-γ elispot analysis ancillary tgfbeta receptor full article pdf tumor factor responsible vascular endothelial cells endothelial cell markers inhibits tumor growth listeria monocytogenes lm-llo-cd105b human endothelial cells anti-vegf therapy lm-llo-cd105a antigen protein results tumor endothelial cells immune response targeting tumour vasculature privacy choices/manage cookies controlling tumor growth reduced tumor growth cd105 sequence present oral dna vaccine anti-angiogenic effects lm-llo-cd105 lm-llo-e7
Schema {🗺️}
WebPage:
mainEntity:
headline:Targeting tumor vasculature with novel Listeria-based vaccines directed against CD105
description:The FDA approval of bevacizumab (Avastin®, Genentech/Roche), a monoclonal antibody raised against human VEGF-A, as second-line therapy for colon and lung carcinoma validated the approach of targeting human tumors with angiogenesis inhibitors. While the VEGF/VEGFR pathway is a viable target for anti-angiogenesis tumor therapy, additional targets involved in tumor neovascularization have been identified. One promising target present specifically on tumor vasculature is endoglin (CD105), a member of the TGF-β receptor complex expressed on vascular endothelium and believed to play a role in angiogenesis. Monoclonal antibody therapy and preventive vaccination against CD105 has met with some success in controlling tumor growth. This report describes the in vivo proof-of-concept studies for two novel therapeutic vaccines, Lm-LLO-CD105A and Lm-LLO-CD105B, directed against CD105 as a strategy to target neovascularization of established tumors. Listeria-based vaccines directed against CD105 lead to therapeutic responses against primary and metastatic tumors in the 4T1-Luc and NT-2 mouse models of breast cancer. In a mouse model for autochthonous Her-2/neu-driven breast cancer, Lm-LLO-CD105A vaccination prevented tumor incidence in 20% of mice by week 58 after birth while all control mice developed tumors by week 40. In comparison with previous Listeria-based vaccines targeting tumor vasculature, Lm-LLO-CD105A and Lm-LLO-CD105B demonstrated equivalent or superior efficacy against two transplantable mouse models of breast cancer. Support is provided for epitope spreading to endogenous tumor antigens and reduction in tumor vascularity after vaccination with Listeria-based CD105 vaccines. Reported here, these CD105 therapeutic vaccines are highly effective in stimulating anti-angiogenesis and anti-tumor immune responses leading to therapeutic efficacy against primary and metastatic breast cancer.
datePublished:2011-03-23T00:00:00Z
dateModified:2011-03-23T00:00:00Z
pageStart:931
pageEnd:942
sameAs:https://doi.org/10.1007/s00262-011-1002-x
keywords:
Endoglin
CD105
Breast cancer
Vasculature
Listeria monocytogenes
Vaccine
Oncology
Immunology
Cancer Research
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-011-1002-x/MediaObjects/262_2011_1002_Fig1_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-011-1002-x/MediaObjects/262_2011_1002_Fig2_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-011-1002-x/MediaObjects/262_2011_1002_Fig3_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-011-1002-x/MediaObjects/262_2011_1002_Fig4_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-011-1002-x/MediaObjects/262_2011_1002_Fig5_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-011-1002-x/MediaObjects/262_2011_1002_Fig6_HTML.gif
isPartOf:
name:Cancer Immunology, Immunotherapy
issn:
1432-0851
0340-7004
volumeNumber:60
type:
Periodical
PublicationVolume
publisher:
name:Springer-Verlag
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Laurence M. Wood
affiliation:
name:University of Pennsylvania
address:
name:Department of Microbiology, University of Pennsylvania, Philadelphia, USA
type:PostalAddress
type:Organization
type:Person
name:Zhen-Kun Pan
affiliation:
name:University of Pennsylvania
address:
name:Department of Microbiology, University of Pennsylvania, Philadelphia, USA
type:PostalAddress
type:Organization
type:Person
name:Patrick Guirnalda
affiliation:
name:University of Pennsylvania
address:
name:Department of Microbiology, University of Pennsylvania, Philadelphia, USA
type:PostalAddress
type:Organization
type:Person
name:Peter Tsai
affiliation:
name:University of Pennsylvania
address:
name:Department of Microbiology, University of Pennsylvania, Philadelphia, USA
type:PostalAddress
type:Organization
type:Person
name:Matthew Seavey
affiliation:
name:University of Pennsylvania
address:
name:Department of Microbiology, University of Pennsylvania, Philadelphia, USA
type:PostalAddress
type:Organization
name:Cephalon, Inc.
address:
name:Cephalon, Inc., West Chester, USA
type:PostalAddress
type:Organization
type:Person
name:Yvonne Paterson
affiliation:
name:University of Pennsylvania
address:
name:Department of Microbiology, University of Pennsylvania, Philadelphia, USA
type:PostalAddress
type:Organization
email:[email protected]
type:Person
isAccessibleForFree:
hasPart:
isAccessibleForFree:
cssSelector:.main-content
type:WebPageElement
type:ScholarlyArticle
context:https://schema.org
ScholarlyArticle:
headline:Targeting tumor vasculature with novel Listeria-based vaccines directed against CD105
description:The FDA approval of bevacizumab (Avastin®, Genentech/Roche), a monoclonal antibody raised against human VEGF-A, as second-line therapy for colon and lung carcinoma validated the approach of targeting human tumors with angiogenesis inhibitors. While the VEGF/VEGFR pathway is a viable target for anti-angiogenesis tumor therapy, additional targets involved in tumor neovascularization have been identified. One promising target present specifically on tumor vasculature is endoglin (CD105), a member of the TGF-β receptor complex expressed on vascular endothelium and believed to play a role in angiogenesis. Monoclonal antibody therapy and preventive vaccination against CD105 has met with some success in controlling tumor growth. This report describes the in vivo proof-of-concept studies for two novel therapeutic vaccines, Lm-LLO-CD105A and Lm-LLO-CD105B, directed against CD105 as a strategy to target neovascularization of established tumors. Listeria-based vaccines directed against CD105 lead to therapeutic responses against primary and metastatic tumors in the 4T1-Luc and NT-2 mouse models of breast cancer. In a mouse model for autochthonous Her-2/neu-driven breast cancer, Lm-LLO-CD105A vaccination prevented tumor incidence in 20% of mice by week 58 after birth while all control mice developed tumors by week 40. In comparison with previous Listeria-based vaccines targeting tumor vasculature, Lm-LLO-CD105A and Lm-LLO-CD105B demonstrated equivalent or superior efficacy against two transplantable mouse models of breast cancer. Support is provided for epitope spreading to endogenous tumor antigens and reduction in tumor vascularity after vaccination with Listeria-based CD105 vaccines. Reported here, these CD105 therapeutic vaccines are highly effective in stimulating anti-angiogenesis and anti-tumor immune responses leading to therapeutic efficacy against primary and metastatic breast cancer.
datePublished:2011-03-23T00:00:00Z
dateModified:2011-03-23T00:00:00Z
pageStart:931
pageEnd:942
sameAs:https://doi.org/10.1007/s00262-011-1002-x
keywords:
Endoglin
CD105
Breast cancer
Vasculature
Listeria monocytogenes
Vaccine
Oncology
Immunology
Cancer Research
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-011-1002-x/MediaObjects/262_2011_1002_Fig1_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-011-1002-x/MediaObjects/262_2011_1002_Fig2_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-011-1002-x/MediaObjects/262_2011_1002_Fig3_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-011-1002-x/MediaObjects/262_2011_1002_Fig4_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-011-1002-x/MediaObjects/262_2011_1002_Fig5_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-011-1002-x/MediaObjects/262_2011_1002_Fig6_HTML.gif
isPartOf:
name:Cancer Immunology, Immunotherapy
issn:
1432-0851
0340-7004
volumeNumber:60
type:
Periodical
PublicationVolume
publisher:
name:Springer-Verlag
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Laurence M. Wood
affiliation:
name:University of Pennsylvania
address:
name:Department of Microbiology, University of Pennsylvania, Philadelphia, USA
type:PostalAddress
type:Organization
type:Person
name:Zhen-Kun Pan
affiliation:
name:University of Pennsylvania
address:
name:Department of Microbiology, University of Pennsylvania, Philadelphia, USA
type:PostalAddress
type:Organization
type:Person
name:Patrick Guirnalda
affiliation:
name:University of Pennsylvania
address:
name:Department of Microbiology, University of Pennsylvania, Philadelphia, USA
type:PostalAddress
type:Organization
type:Person
name:Peter Tsai
affiliation:
name:University of Pennsylvania
address:
name:Department of Microbiology, University of Pennsylvania, Philadelphia, USA
type:PostalAddress
type:Organization
type:Person
name:Matthew Seavey
affiliation:
name:University of Pennsylvania
address:
name:Department of Microbiology, University of Pennsylvania, Philadelphia, USA
type:PostalAddress
type:Organization
name:Cephalon, Inc.
address:
name:Cephalon, Inc., West Chester, USA
type:PostalAddress
type:Organization
type:Person
name:Yvonne Paterson
affiliation:
name:University of Pennsylvania
address:
name:Department of Microbiology, University of Pennsylvania, Philadelphia, USA
type:PostalAddress
type:Organization
email:[email protected]
type:Person
isAccessibleForFree:
hasPart:
isAccessibleForFree:
cssSelector:.main-content
type:WebPageElement
["Periodical","PublicationVolume"]:
name:Cancer Immunology, Immunotherapy
issn:
1432-0851
0340-7004
volumeNumber:60
Organization:
name:Springer-Verlag
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
name:University of Pennsylvania
address:
name:Department of Microbiology, University of Pennsylvania, Philadelphia, USA
type:PostalAddress
name:University of Pennsylvania
address:
name:Department of Microbiology, University of Pennsylvania, Philadelphia, USA
type:PostalAddress
name:University of Pennsylvania
address:
name:Department of Microbiology, University of Pennsylvania, Philadelphia, USA
type:PostalAddress
name:University of Pennsylvania
address:
name:Department of Microbiology, University of Pennsylvania, Philadelphia, USA
type:PostalAddress
name:University of Pennsylvania
address:
name:Department of Microbiology, University of Pennsylvania, Philadelphia, USA
type:PostalAddress
name:Cephalon, Inc.
address:
name:Cephalon, Inc., West Chester, USA
type:PostalAddress
name:University of Pennsylvania
address:
name:Department of Microbiology, University of Pennsylvania, Philadelphia, USA
type:PostalAddress
ImageObject:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
name:Laurence M. Wood
affiliation:
name:University of Pennsylvania
address:
name:Department of Microbiology, University of Pennsylvania, Philadelphia, USA
type:PostalAddress
type:Organization
name:Zhen-Kun Pan
affiliation:
name:University of Pennsylvania
address:
name:Department of Microbiology, University of Pennsylvania, Philadelphia, USA
type:PostalAddress
type:Organization
name:Patrick Guirnalda
affiliation:
name:University of Pennsylvania
address:
name:Department of Microbiology, University of Pennsylvania, Philadelphia, USA
type:PostalAddress
type:Organization
name:Peter Tsai
affiliation:
name:University of Pennsylvania
address:
name:Department of Microbiology, University of Pennsylvania, Philadelphia, USA
type:PostalAddress
type:Organization
name:Matthew Seavey
affiliation:
name:University of Pennsylvania
address:
name:Department of Microbiology, University of Pennsylvania, Philadelphia, USA
type:PostalAddress
type:Organization
name:Cephalon, Inc.
address:
name:Cephalon, Inc., West Chester, USA
type:PostalAddress
type:Organization
name:Yvonne Paterson
affiliation:
name:University of Pennsylvania
address:
name:Department of Microbiology, University of Pennsylvania, Philadelphia, USA
type:PostalAddress
type:Organization
email:[email protected]
PostalAddress:
name:Department of Microbiology, University of Pennsylvania, Philadelphia, USA
name:Department of Microbiology, University of Pennsylvania, Philadelphia, USA
name:Department of Microbiology, University of Pennsylvania, Philadelphia, USA
name:Department of Microbiology, University of Pennsylvania, Philadelphia, USA
name:Department of Microbiology, University of Pennsylvania, Philadelphia, USA
name:Cephalon, Inc., West Chester, USA
name:Department of Microbiology, University of Pennsylvania, Philadelphia, USA
WebPageElement:
isAccessibleForFree:
cssSelector:.main-content
External Links {🔗}(171)
- How much does https://www.springernature.com/gp/authors gross monthly?
- Get to know https://link.springernature.com/home/'s earnings
- https://order.springer.com/public/cart income
- How much money does https://submission.nature.com/new-submission/262/3 make?
- What's the profit of https://www.springernature.com/gp/librarians/licensing/agc/journals?
- How much does http://scholar.google.com/scholar_lookup?&title=Vascular%20reactions%20of%20normal%20and%20malignant%20tissues%20in%20vivo.%20I.%20Vascular%20reactions%20of%20mice%20to%20wounds%20and%20to%20normal%20and%20neoplastic%20transplants&journal=J%20Natl%20Cancer%20Inst&volume=11&issue=3&pages=555-580&publication_year=1945&author=Algire%2CGH&author=Chalkley%2CHW&author=Legallais%2CFY&author=Park%2CHD earn?
- What's the income generated by http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15403011 each month?
- See how much http://scholar.google.com/scholar_lookup?&title=The%20effect%20of%20vascular%20occlusion%20on%20transplanted%20tumors&journal=J%20Natl%20Cancer%20Inst&volume=10&issue=3&pages=565-579&publication_year=1949&author=Youngner%2CJS&author=Algire%2CGH makes per month
- How much money does https://doi.org/10.1056%2FNEJM197111182852108 generate?
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=4938153's financial summary
- http://scholar.google.com/scholar_lookup?&title=Tumor%20angiogenesis%3A%20therapeutic%20implications&journal=N%20Engl%20J%20Med&doi=10.1056%2FNEJM197111182852108&volume=285&issue=21&pages=1182-1186&publication_year=1971&author=Folkman%2CJ's financial summary
- https://doi.org/10.1084%2Fjem.133.2.275's financial summary
- How much money does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=4332371 make?
- How much income does http://scholar.google.com/scholar_lookup?&title=Isolation%20of%20a%20tumor%20factor%20responsible%20for%20angiogenesis&journal=J%20Exp%20Med&doi=10.1084%2Fjem.133.2.275&volume=133&issue=2&pages=275-288&publication_year=1971&author=Folkman%2CJ&author=Merler%2CE&author=Abernathy%2CC&author=Williams%2CG have?
- Profit of http://scholar.google.com/scholar_lookup?&title=&journal=FDA%20Consum&volume=38&issue=3&publication_year=2004
- Profit of https://doi.org/10.4049%2Fjimmunol.0803742
- What's the financial gain of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19380802?
- Revenue of http://scholar.google.com/scholar_lookup?&title=An%20anti-vascular%20endothelial%20growth%20factor%20receptor%202%2Ffetal%20liver%20kinase-1%20Listeria%20monocytogenes%20anti-angiogenesis%20cancer%20vaccine%20for%20the%20treatment%20of%20primary%20and%20metastatic%20Her-2%2Fneu%C2%A0%2B%C2%A0breast%20tumors%20in%20a%20mouse%20model&journal=J%20Immunol&doi=10.4049%2Fjimmunol.0803742&volume=182&issue=9&pages=5537-5546&publication_year=2009&author=Seavey%2CMM&author=Maciag%2CPC&author=Al-Rawi%2CN&author=Sewell%2CD&author=Paterson%2CY
- Profit of https://doi.org/10.1158%2F0008-5472.CAN-08-0287
- How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18829565 generate?
- How much does http://scholar.google.com/scholar_lookup?&title=Cancer%20immunotherapy%20targeting%20the%20high%20molecular%20weight%20melanoma-associated%20antigen%20protein%20results%20in%20a%20broad%20antitumor%20response%20and%20reduction%20of%20pericytes%20in%20the%20tumor%20vasculature&journal=Cancer%20Res&doi=10.1158%2F0008-5472.CAN-08-0287&volume=68&issue=19&pages=8066-8075&publication_year=2008&author=Maciag%2CPC&author=Seavey%2CMM&author=Pan%2CZK&author=Ferrone%2CS&author=Paterson%2CY bring in each month?
- How much does https://doi.org/10.1038%2Fnm1202-794 gross monthly?
- Explore the financials of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=12415261
- What's the monthly income of http://scholar.google.com/scholar_lookup?&title=A%20DNA%20vaccine%20against%20VEGF%20receptor%202%20prevents%20effective%20angiogenesis%20and%20inhibits%20tumor%20growth&journal=Nat%20Med&doi=10.1038%2Fnm1202-794&volume=8&issue=12&pages=1369-1375&publication_year=2002&author=Niethammer%2CAG&author=Xiang%2CR&author=Becker%2CJC&author=Wodrich%2CH&author=Pertl%2CU&author=Karsten%2CG?
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15687710's revenue stream
- Explore the financials of http://scholar.google.com/scholar_lookup?&title=DNA%20vaccines%20suppress%20angiogenesis%20and%20protect%20against%20growth%20of%20breast%20cancer%20metastases&journal=Breast%20Dis&volume=20&pages=81-91&publication_year=2004&author=Mizutani%2CN&author=Luo%2CY&author=Mizutani%2CM&author=Reisfeld%2CRA&author=Xiang%2CR
- What's the financial gain of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16565828?
- Get to know what's the income of http://scholar.google.com/scholar_lookup?&title=Endoglin%20%28CD105%29%20is%20a%20target%20for%20an%20oral%20DNA%20vaccine%20against%20breast%20cancer&journal=Cancer%20Immunol%20Immunother&doi=10.1007%2Fs00262-006-0155-5&volume=55&issue=12&pages=1565-1574&publication_year=2006&author=Lee%2CSH&author=Mizutani%2CN&author=Mizutani%2CM&author=Luo%2CY&author=Zhou%2CH&author=Kaplan%2CC
- How much does https://doi.org/10.1083%2Fjcb.133.5.1109 net monthly?
- How profitable is http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=8655583?
- How much income is http://scholar.google.com/scholar_lookup?&title=Endoglin%20modulates%20cellular%20responses%20to%20TGF-beta%201&journal=J%20Cell%20Biol&doi=10.1083%2Fjcb.133.5.1109&volume=133&issue=5&pages=1109-1121&publication_year=1996&author=Lastres%2CP&author=Letamendia%2CA&author=Zhang%2CH&author=Rius%2CC&author=Almendro%2CN&author=Raab%2CU earning monthly?
- How much does https://doi.org/10.1126%2Fscience.284.5419.1534 bring in each month?
- What's the profit of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10348742?
- Profit of http://scholar.google.com/scholar_lookup?&title=Defective%20angiogenesis%20in%20mice%20lacking%20endoglin&journal=Science&doi=10.1126%2Fscience.284.5419.1534&volume=284&issue=5419&pages=1534-1537&publication_year=1999&author=Li%2CDY&author=Sorensen%2CLK&author=Brooke%2CBS&author=Urness%2CLD&author=Davis%2CEC&author=Taylor%2CDG
- See how much https://doi.org/10.1016%2FS1050-1738%2801%2900062-7 makes per month
- What's the income of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=11343967?
- How much does http://scholar.google.com/scholar_lookup?&title=Endoglin-deficient%20mice%2C%20a%20unique%20model%20to%20study%20hereditary%20hemorrhagic%20telangiectasia&journal=Trends%20Cardiovasc%20Med&doi=10.1016%2FS1050-1738%2801%2900062-7&volume=10&issue=7&pages=279-285&publication_year=2000&author=Bourdeau%2CA&author=Faughnan%2CME&author=Letarte%2CM pull in?
- Explore the financials of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10627280
- What's the revenue for http://scholar.google.com/scholar_lookup?&title=CD105%20antagonizes%20the%20inhibitory%20signaling%20of%20transforming%20growth%20factor%20beta1%20on%20human%20vascular%20endothelial%20cells&journal=FASEB%20J&volume=14&issue=1&pages=55-64&publication_year=2000&author=Li%2CC&author=Hampson%2CIN&author=Hampson%2CL&author=Kumar%2CP&author=Bernabeu%2CC&author=Kumar%2CS?
- What are the earnings of https://doi.org/10.1002%2F1097-0029%2820010215%2952%3A4%3C437%3A%3AAID-JEMT1029%3E3.0.CO%3B2-G?
- What's the financial gain of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=11170303?
- How much does http://scholar.google.com/scholar_lookup?&title=Angiogenesis%20in%20breast%20cancer%3A%20the%20role%20of%20transforming%20growth%20factor%20beta%20and%20CD105&journal=Microsc%20Res%20Tech&doi=10.1002%2F1097-0029%2820010215%2952%3A4%3C437%3A%3AAID-JEMT1029%3E3.0.CO%3B2-G&volume=52&issue=4&pages=437-449&publication_year=2001&author=Li%2CC&author=Guo%2CB&author=Bernabeu%2CC&author=Kumar%2CS earn?
- Check the income stats for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=1326540
- What's the income generated by http://scholar.google.com/scholar_lookup?&title=Endoglin%20is%20a%20component%20of%20the%20transforming%20growth%20factor-beta%20receptor%20system%20in%20human%20endothelial%20cells&journal=J%20Biol%20Chem&volume=267&issue=27&pages=19027-19030&publication_year=1992&author=Cheifetz%2CS&author=Bellon%2CT&author=Cales%2CC&author=Vera%2CS&author=Bernabeu%2CC&author=Massague%2CJ each month?
- Revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19112825
- How much does http://scholar.google.com/scholar_lookup?&title=TGF%20beta%20signalling%20accessory%20receptors&journal=Postepy%20Biochem&volume=54&issue=3&pages=264-273&publication_year=2008&author=Mokrosinski%2CJ&author=Krajewska%2CWM generate monthly?
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19607914's total income per month
- How much revenue does http://scholar.google.com/scholar_lookup?&title=The%20emerging%20role%20of%20TGF-beta%20superfamily%20coreceptors%20in%20cancer&journal=Biochim%20Biophys%20Acta&volume=1792&issue=10&pages=954-973&publication_year=2009&author=Bernabeu%2CC&author=Lopez-Novoa%2CJM&author=Quintanilla%2CM produce monthly?
- What's the monthly money flow for https://doi.org/10.1074%2Fjbc.M207160200?
- Find out how much http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=12228247 earns monthly
- What's the monthly income of http://scholar.google.com/scholar_lookup?&title=Endoglin%20expression%20is%20regulated%20by%20transcriptional%20cooperation%20between%20the%20hypoxia%20and%20transforming%20growth%20factor-beta%20pathways&journal=J%20Biol%20Chem&doi=10.1074%2Fjbc.M207160200&volume=277&issue=46&pages=43799-43808&publication_year=2002&author=Sanchez-Elsner%2CT&author=Botella%2CLM&author=Velasco%2CB&author=Langa%2CC&author=Bernabeu%2CC?
- Check the income stats for https://doi.org/10.1016%2FS0012-1606%2803%2900158-1
- How much profit does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=12941632 generate?
- Discover the revenue of http://scholar.google.com/scholar_lookup?&title=Loss%20of%20distinct%20arterial%20and%20venous%20boundaries%20in%20mice%20lacking%20endoglin%2C%20a%20vascular-specific%20TGFbeta%20coreceptor&journal=Dev%20Biol&doi=10.1016%2FS0012-1606%2803%2900158-1&volume=261&issue=1&pages=235-250&publication_year=2003&author=Sorensen%2CLK&author=Brooke%2CBS&author=Li%2CDY&author=Urness%2CLD
- How much income is https://doi.org/10.1006%2Fdbio.1999.9534 earning monthly?
- What are the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10625534?
- What's http://scholar.google.com/scholar_lookup?&title=Endoglin%2C%20an%20ancillary%20TGFbeta%20receptor%2C%20is%20required%20for%20extraembryonic%20angiogenesis%20and%20plays%20a%20key%20role%20in%20heart%20development&journal=Dev%20Biol&doi=10.1006%2Fdbio.1999.9534&volume=217&issue=1&pages=42-53&publication_year=2000&author=Arthur%2CHM&author=Ure%2CJ&author=Smith%2CAJ&author=Renforth%2CG&author=Wilson%2CDI&author=Torsney%2CE's gross income?
- How much money does http://scholar.google.com/scholar_lookup?&title=Critical%20role%20of%20endoglin%20in%20tumor%20cell%20plasticity%20of%20Ewing%20sarcoma%20and%20melanoma&journal=Oncogene&volume=30&issue=3&pages=334-345&publication_year=2011&author=Pardali%2CE&author=Schaft%2CDW&author=Wiercinska%2CE&author=Gorter%2CA&author=Hogendoorn%2CPC&author=Griffioen%2CAW make?
- Income figures for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17108712
- Monthly income for http://scholar.google.com/scholar_lookup?&title=Reduced%20tumor%20growth%20and%20angiogenesis%20in%20endoglin-haploinsufficient%20mice&journal=Tumour%20Biol&volume=28&issue=1&pages=1-8&publication_year=2007&author=Duwel%2CA&author=Eleno%2CN&author=Jerkic%2CM&author=Arevalo%2CM&author=Bolanos%2CJP&author=Bernabeu%2CC
- How much income does https://doi.org/10.1038%2Fsj.onc.1208644 have?
- Explore the financials of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15806144
- How much income does http://scholar.google.com/scholar_lookup?&title=Characterization%20of%20murine%20S-endoglin%20isoform%20and%20its%20effects%20on%20tumor%20development&journal=Oncogene&doi=10.1038%2Fsj.onc.1208644&volume=24&issue=27&pages=4450-4461&publication_year=2005&author=Perez-Gomez%2CE&author=Eleno%2CN&author=Lopez-Novoa%2CJM&author=Ramirez%2CJR&author=Velasco%2CB&author=Letarte%2CM have?
- What's the financial outcome of https://doi.org/10.1158%2F0008-5472.CAN-07-1348?
- Profit of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17974968
- How much profit does http://scholar.google.com/scholar_lookup?&title=A%20role%20for%20endoglin%20as%20a%20suppressor%20of%20malignancy%20during%20mouse%20skin%20carcinogenesis&journal=Cancer%20Res&doi=10.1158%2F0008-5472.CAN-07-1348&volume=67&issue=21&pages=10268-10277&publication_year=2007&author=Perez-Gomez%2CE&author=Villa-Morales%2CM&author=Santos%2CJ&author=Fernandez-Piqueras%2CJ&author=Gamallo%2CC&author=Dotor%2CJ make?
- What's the financial intake of http://scholar.google.com/scholar_lookup?&title=Targeting%20the%20tumour%20vasculature%3A%20insights%20from%20physiological%20angiogenesis&journal=Nat%20Rev%20Cancer&volume=10&issue=7&pages=505-514&publication_year=2010&author=Chung%2CAS&author=Lee%2CJ&author=Ferrara%2CN?
- How much money does https://doi.org/10.1002%2F%28SICI%291097-0215%2820000320%2989%3A2%3C122%3A%3AAID-IJC4%3E3.0.CO%3B2-M generate?
- Financial intake of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10754488
- Financial intake of http://scholar.google.com/scholar_lookup?&title=Plasma%20levels%20of%20soluble%20CD105%20correlate%20with%20metastasis%20in%20patients%20with%20breast%20cancer&journal=Int%20J%20Cancer&doi=10.1002%2F%28SICI%291097-0215%2820000320%2989%3A2%3C122%3A%3AAID-IJC4%3E3.0.CO%3B2-M&volume=89&issue=2&pages=122-126&publication_year=2000&author=Li%2CC&author=Guo%2CB&author=Wilson%2CPB&author=Stewart%2CA&author=Byrne%2CG&author=Bundred%2CN
- How much income does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=11297243 have?
- How much income is http://scholar.google.com/scholar_lookup?&title=Association%20of%20serum%20endoglin%20with%20metastasis%20in%20patients%20with%20colorectal%2C%20breast%2C%20and%20other%20solid%20tumors%2C%20and%20suppressive%20effect%20of%20chemotherapy%20on%20the%20serum%20endoglin&journal=Clin%20Cancer%20Res&volume=7&issue=3&pages=524-532&publication_year=2001&author=Takahashi%2CN&author=Kawanishi-Tabata%2CR&author=Haba%2CA&author=Tabata%2CM&author=Haruta%2CY&author=Tsai%2CH earning monthly?
- What's the income of https://doi.org/10.1002%2Fijc.2910540303?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=8509210 generate monthly?
- How much money does http://scholar.google.com/scholar_lookup?&title=A%20monoclonal%20antibody%20detects%20heterogeneity%20in%20vascular%20endothelium%20of%20tumours%20and%20normal%20tissues&journal=Int%20J%20Cancer&doi=10.1002%2Fijc.2910540303&volume=54&issue=3&pages=363-370&publication_year=1993&author=Wang%2CJM&author=Kumar%2CS&author=Pye%2CD&author=Agthoven%2CAJ&author=Krupinski%2CJ&author=Hunter%2CRD make?
- How much profit does https://doi.org/10.1093%2Fjnci%2F86.5.386 generate?
- What's the monthly income of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=7508519?
- What's http://scholar.google.com/scholar_lookup?&title=Breast%20carcinoma%3A%20comparative%20study%20of%20tumor%20vasculature%20using%20two%20endothelial%20cell%20markers&journal=J%20Natl%20Cancer%20Inst&doi=10.1093%2Fjnci%2F86.5.386&volume=86&issue=5&pages=386-388&publication_year=1994&author=Wang%2CJM&author=Kumar%2CS&author=Pye%2CD&author=Haboubi%2CN&author=al-Nakib%2CL's gross income?
- How much money does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=9815965 make?
- What's the financial intake of http://scholar.google.com/scholar_lookup?&title=Up-regulation%20of%20endoglin%20on%20vascular%20endothelial%20cells%20in%20human%20solid%20tumors%3A%20implications%20for%20diagnosis%20and%20therapy&journal=Clin%20Cancer%20Res&volume=1&issue=12&pages=1623-1634&publication_year=1995&author=Burrows%2CFJ&author=Derbyshire%2CEJ&author=Tazzari%2CPL&author=Amlot%2CP&author=Gazdar%2CAF&author=King%2CSW?
- How much does https://doi.org/10.1002%2F%28SICI%291097-0215%2819990827%2982%3A5%3C737%3A%3AAID-IJC18%3E3.0.CO%3B2-8 make?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10417773 make?
- Learn how profitable http://scholar.google.com/scholar_lookup?&title=Antiangiogenic%20radioimmunotherapy%20of%20human%20solid%20tumors%20in%20SCID%20mice%20using%20%28125%29I-labeled%20anti-endoglin%20monoclonal%20antibodies&journal=Int%20J%20Cancer&doi=10.1002%2F%28SICI%291097-0215%2819990827%2982%3A5%3C737%3A%3AAID-IJC18%3E3.0.CO%3B2-8&volume=82&issue=5&pages=737-742&publication_year=1999&author=Tabata%2CM&author=Kondo%2CM&author=Haruta%2CY&author=Seon%2CBK is on a monthly basis
- How much revenue does https://doi.org/10.2174%2F1573406053402479 produce monthly?
- Check the income stats for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16789887
- Monthly income for http://scholar.google.com/scholar_lookup?&title=Cytotoxicity%20of%20an%20ebulin%20l-anti-human%20CD105%20immunotoxin%20on%20mouse%20fibroblasts%20%28L929%29%20and%20rat%20myoblasts%20%28L6E9%29%20cells%20expressing%20human%20CD105&journal=Med%20Chem&doi=10.2174%2F1573406053402479&volume=1&issue=1&pages=65-70&publication_year=2005&author=Benitez%2CJ&author=Ferreras%2CJM&author=Munoz%2CR&author=Arias%2CY&author=Iglesias%2CR&author=Cordoba-Diaz%2CM
- What is the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10037187?
- What's the income generated by http://scholar.google.com/scholar_lookup?&title=Induction%20of%20lasting%20complete%20regression%20of%20preformed%20distinct%20solid%20tumors%20by%20targeting%20the%20tumor%20vasculature%20using%20two%20new%20anti-endoglin%20monoclonal%20antibodies&journal=Clin%20Cancer%20Res&volume=5&issue=2&pages=371-382&publication_year=1999&author=Matsuno%2CF&author=Haruta%2CY&author=Kondo%2CM&author=Tsai%2CH&author=Barcos%2CM&author=Seon%2CBK each month?
- What's the total monthly financial gain of https://doi.org/10.1073%2Fpnas.89.22.10578?
- How profitable is http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=1359541?
- How much revenue does http://scholar.google.com/scholar_lookup?&title=Expression%20of%20the%20neu%20protooncogene%20in%20the%20mammary%20epithelium%20of%20transgenic%20mice%20induces%20metastatic%20disease&journal=Proc%20Natl%20Acad%20Sci%20USA&doi=10.1073%2Fpnas.89.22.10578&volume=89&issue=22&pages=10578-10582&publication_year=1992&author=Guy%2CCT&author=Webster%2CMA&author=Schaller%2CM&author=Parsons%2CTJ&author=Cardiff%2CRD&author=Muller%2CWJ bring in?
- What are the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10910070?
- Get to know http://scholar.google.com/scholar_lookup?&title=HER-2%2Fneu%20is%20a%20tumor%20rejection%20target%20in%20tolerized%20HER-2%2Fneu%20transgenic%20mice&journal=Cancer%20Res&volume=60&issue=13&pages=3569-3576&publication_year=2000&author=Reilly%2CRT&author=Gottlieb%2CMB&author=Ercolini%2CAM&author=Machiels%2CJP&author=Kane%2CCE&author=Okoye%2CFI's earnings
- What is the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=1540948?
- What is the monthly revenue of http://scholar.google.com/scholar_lookup?&title=Selective%20events%20in%20the%20metastatic%20process%20defined%20by%20analysis%20of%20the%20sequential%20dissemination%20of%20subpopulations%20of%20a%20mouse%20mammary%20tumor&journal=Cancer%20Res&volume=52&issue=6&pages=1399-1405&publication_year=1992&author=Aslakson%2CCJ&author=Miller%2CFR?
- Check the income stats for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18691423
- How much money does http://scholar.google.com/scholar_lookup?&title=Imagable%204T1%20model%20for%20the%20study%20of%20late%20stage%20breast%20cancer&journal=BMC%20Cancer&doi=10.1186%2F1471-2407-8-228&volume=8&publication_year=2008&author=Tao%2CK&author=Fang%2CM&author=Alroy%2CJ&author=Sahagian%2CGG make?
- What's http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17131121's gross income?
- Learn about the earnings of http://scholar.google.com/scholar_lookup?&title=In%20the%20FVB%2FN%20HER-2%2Fneu%20transgenic%20mouse%20both%20peripheral%20and%20central%20tolerance%20limit%20the%20immune%20response%20targeting%20HER-2%2Fneu%20induced%20by%20Listeria%20monocytogenes-based%20vaccines&journal=Cancer%20Immunol%20Immunother&doi=10.1007%2Fs00262-006-0237-4&volume=56&issue=6&pages=927-938&publication_year=2007&author=Singh%2CR&author=Paterson%2CY
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=1662559's financial summary
- What's http://scholar.google.com/scholar_lookup?&title=Expression%20of%20activated%20oncogenes%20in%20the%20murine%20mammary%20gland%3A%20transgenic%20models%20for%20human%20breast%20cancer&journal=Cancer%20Metastasis%20Rev&doi=10.1007%2FBF00050793&volume=10&issue=3&pages=217-227&publication_year=1991&author=Muller%2CWJ's gross income?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16248280 gross monthly?
- How much revenue does http://scholar.google.com/scholar_lookup?&title=Listeria-based%20vaccines%20for%20cancer%20treatment&journal=Curr%20Opin%20Mol%20Ther&volume=7&issue=5&pages=454-460&publication_year=2005&author=Paterson%2CY&author=Maciag%2CPC produce monthly?
- Earnings of https://doi.org/10.1158%2F0008-5472.CAN-08-4855
- What's the monthly money flow for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19584282?
- How much does http://scholar.google.com/scholar_lookup?&title=High%20efficacy%20of%20a%20Listeria-based%20vaccine%20against%20metastatic%20breast%20cancer%20reveals%20a%20dual%20mode%20of%20action&journal=Cancer%20Res&doi=10.1158%2F0008-5472.CAN-08-4855&volume=69&issue=14&pages=5860-5866&publication_year=2009&author=Kim%2CSH&author=Castro%2CF&author=Paterson%2CY&author=Gravekamp%2CC pull in?
- How much does https://doi.org/10.1073%2Fpnas.93.18.9730 make?
- Discover the revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=8790399
- What's the financial outcome of http://scholar.google.com/scholar_lookup?&title=The%20immunodominant%20major%20histocompatibility%20complex%20class%20I-%20restricted%20antigen%20of%20a%20murine%20colon%20tumor%20derives%20from%20an%20endogenous%20retroviral%20gene%20product&journal=Proc%20Natl%20Acad%20Sci%20USA&doi=10.1073%2Fpnas.93.18.9730&volume=93&issue=18&pages=9730-9735&publication_year=1996&author=Huang%2CAY&author=Gulden%2CPH&author=Woods%2CAS&author=Thomas%2CMC&author=Tong%2CCD&author=Wang%2CW?
- https://doi.org/10.1083%2Fjcb.114.5.1059's total income per month
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=1874786 earn?
- Earnings of http://scholar.google.com/scholar_lookup?&title=Molecular%20and%20cellular%20properties%20of%20PECAM-1%20%28endoCAM%2FCD31%29%3A%20a%20novel%20vascular%20cell-cell%20adhesion%20molecule&journal=J%20Cell%20Biol&doi=10.1083%2Fjcb.114.5.1059&volume=114&issue=5&pages=1059-1068&publication_year=1991&author=Albelda%2CSM&author=Muller%2CWA&author=Buck%2CCA&author=Newman%2CPJ
- How much does https://doi.org/10.1002%2F%28SICI%291097-0215%2819990517%2981%3A4%3C568%3A%3AAID-IJC11%3E3.0.CO%3B2-X pull in?
- What's the monthly money flow for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10225446?
- http://scholar.google.com/scholar_lookup?&title=Elevated%20expression%20of%20endoglin%2C%20a%20component%20of%20the%20TGF-beta-receptor%20complex%2C%20correlates%20with%20proliferation%20of%20tumor%20endothelial%20cells&journal=Int%20J%20Cancer&doi=10.1002%2F%28SICI%291097-0215%2819990517%2981%3A4%3C568%3A%3AAID-IJC11%3E3.0.CO%3B2-X&volume=81&issue=4&pages=568-572&publication_year=1999&author=Miller%2CDW&author=Graulich%2CW&author=Karges%2CB&author=Stahl%2CS&author=Ernst%2CM&author=Ramaswamy%2CA's total income per month
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10815930 pull in?
- What's the financial intake of http://scholar.google.com/scholar_lookup?&title=Endoglin%20is%20a%20suitable%20target%20for%20efficient%20imaging%20of%20solid%20tumors%3A%20in%20vivo%20evidence%20in%20a%20canine%20mammary%20carcinoma%20model&journal=Clin%20Cancer%20Res&volume=6&issue=5&pages=2037-2043&publication_year=2000&author=Fonsatti%2CE&author=Jekunen%2CAP&author=Kairemo%2CKJ&author=Coral%2CS&author=Snellman%2CM&author=Nicotra%2CMR?
- What is the earnings of http://scholar.google.com/scholar_lookup?&title=Myeloid-derived%20suppressor%20cells%20in%20mammary%20tumor%20progression%20in%20FVB%20Neu%20transgenic%20mice&journal=Cancer%20Immunol%20Immunother&volume=59&issue=1&pages=47-62&publication_year=2010&author=Abe%2CF&author=Dafferner%2CAJ&author=Donkor%2CM&author=Westphal%2CSN&author=Scholar%2CEM&author=Solheim%2CJC?
- What's https://doi.org/10.1016%2Fj.intimp.2009.03.021's gross income?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19362167 net monthly?
- Revenue of http://scholar.google.com/scholar_lookup?&title=Mammary%20tumor%20heterogeneity%20in%20the%20expansion%20of%20myeloid-derived%20suppressor%20cells&journal=Int%20Immunopharmacol&doi=10.1016%2Fj.intimp.2009.03.021&volume=9&issue=7%E2%80%938&pages=937-948&publication_year=2009&author=Donkor%2CMK&author=Lahue%2CE&author=Hoke%2CTA&author=Shafer%2CLR&author=Coskun%2CU&author=Solheim%2CJC
- What's the revenue for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17279610?
- What's the profit of http://scholar.google.com/scholar_lookup?&title=Listeria-based%20vaccines%20can%20overcome%20tolerance%20by%20expanding%20low%20avidity%20CD8%C2%A0%2B%C2%A0T%20cells%20capable%20of%20eradicating%20a%20solid%20tumor%20in%20a%20transgenic%20mouse%20model%20of%20cancer&journal=Cancer%20Immun&volume=7&publication_year=2007&author=Souders%2CNC&author=Sewell%2CDA&author=Pan%2CZK&author=Hussain%2CSF&author=Rodriguez%2CA&author=Wallecha%2CA?
- How much does https://doi.org/10.1152%2Fajpheart.00133.2005 gross monthly?
- How much money does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16172168 make?
- Learn about the earnings of http://scholar.google.com/scholar_lookup?&title=VEGF-dependent%20plasticity%20of%20fenestrated%20capillaries%20in%20the%20normal%20adult%20microvasculature&journal=Am%20J%20Physiol%20Heart%20Circ%20Physiol&doi=10.1152%2Fajpheart.00133.2005&volume=290&issue=2&pages=H560-H576&publication_year=2006&author=Kamba%2CT&author=Tam%2CBY&author=Hashizume%2CH&author=Haskell%2CA&author=Sennino%2CB&author=Mancuso%2CMR
- How much revenue does https://doi.org/10.1038%2Fsj.bjc.6603813 generate?
- How much profit does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17519900 make?
- What's the financial gain of http://scholar.google.com/scholar_lookup?&title=Mechanisms%20of%20adverse%20effects%20of%20anti-VEGF%20therapy%20for%20cancer&journal=Br%20J%20Cancer&doi=10.1038%2Fsj.bjc.6603813&volume=96&issue=12&pages=1788-1795&publication_year=2007&author=Kamba%2CT&author=McDonald%2CDM?
- Discover the revenue of https://doi.org/10.2741%2F3504
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19273326's total income per month
- How much profit is http://scholar.google.com/scholar_lookup?&title=Tumor%20angiogenesis%20and%20molecular%20targets%20for%20therapy&journal=Front%20Biosci&doi=10.2741%2F3504&volume=14&pages=3962-3973&publication_year=2009&author=Cao%2CY making per month?
- How much profit does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15856228 make?
- How much money does http://scholar.google.com/scholar_lookup?&title=Antiangiogenic%20chimeric%20anti-endoglin%20%28CD105%29%20antibody%3A%20pharmacokinetics%20and%20immunogenicity%20in%20nonhuman%20primates%20and%20effects%20of%20doxorubicin&journal=Cancer%20Immunol%20Immunother&doi=10.1007%2Fs00262-005-0691-4&volume=55&issue=2&pages=140-150&publication_year=2006&author=Shiozaki%2CK&author=Harada%2CN&author=Greco%2CWR&author=Haba%2CA&author=Uneda%2CS&author=Tsai%2CH generate?
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=12734365's financial summary
- What's the income of http://scholar.google.com/scholar_lookup?&title=The%20induction%20of%20HIV%20Gag-specific%20CD8%C2%A0%2B%C2%A0T%20cells%20in%20the%20spleen%20and%20gut-associated%20lymphoid%20tissue%20by%20parenteral%20or%20mucosal%20immunization%20with%20recombinant%20Listeria%20monocytogenes%20HIV%20Gag&journal=J%20Immunol&volume=170&issue=10&pages=5176-5187&publication_year=2003&author=Peters%2CC&author=Peng%2CX&author=Douven%2CD&author=Pan%2CZK&author=Paterson%2CY?
- How much does https://doi.org/10.1016%2Fj.vaccine.2009.04.041 generate monthly?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19389451 net monthly?
- What's the financial gain of http://scholar.google.com/scholar_lookup?&title=The%20first%20clinical%20use%20of%20a%20live-attenuated%20Listeria%20monocytogenes%20vaccine%3A%20a%20Phase%20I%20safety%20study%20of%20Lm-LLO-E7%20in%20patients%20with%20advanced%20carcinoma%20of%20the%20cervix&journal=Vaccine&doi=10.1016%2Fj.vaccine.2009.04.041&volume=27&issue=30&pages=3975-3983&publication_year=2009&author=Maciag%2CPC&author=Radulovic%2CS&author=Rothman%2CJ?
- What are the earnings of https://citation-needed.springer.com/v2/references/10.1007/s00262-011-1002-x?format=refman&flavour=references?
- How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Laurence%20M.%20Wood bring in each month?
- Profit of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Laurence%20M.%20Wood%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- How profitable is https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Zhen-Kun%20Pan?
- Find out how much https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Zhen-Kun%20Pan%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en earns monthly
- How much profit does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Patrick%20Guirnalda make?
- https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Patrick%20Guirnalda%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en income
- What is the monthly revenue of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Peter%20Tsai?
- How profitable is https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Peter%20Tsai%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- What's the total monthly financial gain of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Matthew%20Seavey?
- What's the total monthly financial gain of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Matthew%20Seavey%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Yvonne%20Paterson generate monthly?
- How much revenue does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Yvonne%20Paterson%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en generate?
- Learn how profitable https://static-content.springer.com/esm/art%3A10.1007%2Fs00262-011-1002-x/MediaObjects/262_2011_1002_MOESM1_ESM.eps is on a monthly basis
- How much money does https://s100.copyright.com/AppDispatchServlet?title=Targeting%20tumor%20vasculature%20with%20novel%20Listeria-based%20vaccines%20directed%20against%20CD105&author=Laurence%20M.%20Wood%20et%20al&contentID=10.1007%2Fs00262-011-1002-x©right=Springer-Verlag&publication=0340-7004&publicationDate=2011-03-23&publisherName=SpringerNature&orderBeanReset=true generate?
- Learn about the earnings of https://citation-needed.springer.com/v2/references/10.1007/s00262-011-1002-x?format=refman&flavour=citation
- See how much https://authorservices.springernature.com/go/sn/?utm_source=SNLinkfooter&utm_medium=Web&utm_campaign=SNReferral makes per month
- Explore the financials of https://www.springernature.com/gp/open-research/about/the-fundamentals-of-open-access-and-open-research
- https://www.springernature.com/gp/products's revenue stream
- How much profit does https://www.springernature.com/gp/librarians generate?
- Financial intake of https://www.springernature.com/gp/societies
- Income figures for https://www.springernature.com/gp/partners
- Get to know what's the income of https://www.springer.com/
- What's the income generated by https://www.nature.com/ each month?
- Find out how much https://www.biomedcentral.com/ earns monthly
- Discover the revenue of https://www.palgrave.com/
- How much does https://www.apress.com/ bring in each month?
- What are the earnings of https://www.springernature.com/gp/legal/ccpa?
- How much income does https://www.springernature.com/gp/info/accessibility have?
- How much money does https://support.springernature.com/en/support/home generate?
- What are the total earnings of https://support.springernature.com/en/support/solutions/articles/6000255911-subscription-cancellations?
- How much income does https://www.springernature.com/ have?
Analytics and Tracking {📊}
- Google Tag Manager
Libraries {📚}
- Clipboard.js
- Prism.js
CDN Services {📦}
- Crossref